U.S. Senators Cory Booker (D-N.J.) and Rand Paul (R-KY) have drafted the Breakthrough Therapies Act, which would enable the Drug Enforcement Agency (DEA) to research rescheduling Schedule I drugs such as psilocybin and MDMA to Schedule II. Rescheduling would make it easier for pharmaceutical companies to investigate the therapeutic potential of psilocybin and MDMA. An…